Dermatology Clinical Trials - Alan R. Shalita Clinical Research Unit
We are recruiting patients for our active clinical trials. If you are interested in participating or obtaining more information, please contact our Dermatology Research Department at (718) 270-1229.
Currently Enrolling
PSORIASIS
ENROLLING NOW! Apremilast (Otezla) (SUNY – Dr. Jakus)
- Children ages 6-17 years old
- Mild or Moderate Plaque Psoriasis
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
ENROLLING NOW! Cardiovascular Disease Prevention for Psoriasis and Psoriatic Artritis (CP3) (SUNY – Dr. Jakus)
- Age 40-75
- Being seen by a dermatology provider for the primary encounter of psoriasis
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
ATOPIC DERMATITIS
ENROLLING NOW! Soquelitinib (SUNY – Dr. Jakus)
- Ages 18+
- Moderate to severe atopic dermatitis
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
VITILIGO
ENROLLING NOW! Ruxolitinib in Pediatric Non-Segmental Vitiligo (SUNY – Dr. Jakus)
- Ages 2 to <12 years
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
HIDRADENITIS SUPPURATIVA
RECRUITING SOON! Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (SUNY- Dr. Jakus)
- Ages 12+
- Mild to moderate HS
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
ATOPIC DERMATITIS
RECRUITING SOON! Investigational compound(s) in patients with atopic dermatitis
- Ages 18+
- Moderate to severe Atopic Dermatitis
Phone: (347) 286-8825, Email: tristi.edwards@downstate.edu
OTHER
Psoriasis (SUNY- Dr. Lee)
NEW: After completion of the phase IIb psoriasis trial, a first-in-class botanical topical cream will be tested in a placebo-controlled phase Iii study for adults ages 18-70 (SUNY-Dr. Heilman) and for peds ages 2-12 (SUNY-Dr. Glick). Sponsored by Psoriasis Institute of Guangzhou (PRIG), China. ClinicalTrials.gov/NCT03372811
Ongoing recruitment: 50 adult subjects with mild to moderate psoriasis (BSA between 1 to 20). The total participation time will be 12 weeks: 8 weeks of treatment period with 4 additional weeks for extended assessment/evaluation.
Upcoming recruitment for 10 ped patients (date to start: to be announced)
Please contact Neal Gupta, MD or Wei-Li Lee, PhD at the department of dermatology at (718) 270-1229
Anticipating Enrollment Soon
PSORIASIS
Oral Phosphodiesterase Inhibitor In Mild-Moderate Pediatric Psoriasis (SUNY – Dr. Jakus)
Oral PDE4 inhibitor for pediatric patients with mild-moderate psoriasis; ages 6-17 yo, 32 weeks of active treatment
HIDRADENITIS SUPPURATIVA
HS and Laser Hair Removal
Adjunct treatment for hidradenitis suppurativa with hair removal laser
Contact Information
For Patients:
We make our best effort to keep this page current, however the study list may not be comprehensive as our studies change all the time. For more information, please feel free to reach out to us. We are happy to answer any questions you may have. When emailing, please indicate the study title in the subject line: (ie. "PSORIASIS", "ACNE"). See below for our contact information.
For Physicians:
Information on all interested patients should be forwarded to our fellows as soon as possible. Patients should also be given the information below to contact our offices directly.
Jeannette Jakus, MD, MBA
Director of Clinical Trials & Research
Jeannette.Jakus@downstate.edu
Corinna Psomadakis, MD
(Dr. Jakus's studies) Dermatology Research Fellow - Clinical Trials Corinna.Psomadakis@downstate.edu
Beatrice Wojuola
Clinical Research Coordinator
Beatrice.Wojuola@downstate.edu
Phone: (718) 270-1229
Email: DermResearch@downstate.edu